Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Changes in antidepressant use in Australia: A nationwide analysis (2015–2021)
Juliana de Oliveira Costa, M. Gillies, Andrea L. Schaffer, et al.
Australian & New Zealand Journal of Psychiatry (2022) Vol. 57, Iss. 1, pp. 49-57
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022)
Jialing Lin, Sallie‐Anne Pearson, Jerry R. Greenfield, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 9, pp. 1239-1248
Open Access | Times Cited: 19
Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic
Mikael Tiger, Giulio Castelpietra, Rikke Wesselhöeft, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Exploring perceived barriers and attitudes in young adults towards antidepressant pharmacotherapy, including the implementation of pharmacogenetic testing to optimize prescription practices
Bradley Roberts, Zahra Cooper, Georgia Landery, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Addressing the undertreatment of mood disorders in Australian youth
Jason P. Connor, James G. Scott, Wayne Hall, et al.
Australian & New Zealand Journal of Psychiatry (2025)
Closed Access
Declining Life Satisfaction and Happiness Among Young Adults in Six English-Speaking Countries
Jean M. Twenge, David G. Blanchflower
SSRN Electronic Journal (2025)
Closed Access
Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID‐19 pandemic, 2013–2021: a retrospective cohort study
Stephen J. Wood, Jenni Ilomäki, Jacqueline F. Gould, et al.
The Medical Journal of Australia (2023) Vol. 219, Iss. 1, pp. 18-25
Open Access | Times Cited: 15
National Trends in Antidepressant Use in Australian Residential Aged Care Facilities (2006–2019)
Georgina A. Hughes, Maria C. Inacio, Debra Rowett, et al.
Journal of the American Medical Directors Association (2024) Vol. 25, Iss. 6, pp. 104957-104957
Closed Access | Times Cited: 4
Antidepressants and COVID-19: Increased use, occurrence in water and effects and consequences on aquatic environment. A review
Antón Puga, Manuela M. Moreira, M.Á. Sanromán, et al.
The Science of The Total Environment (2024) Vol. 953, pp. 175993-175993
Open Access | Times Cited: 3
Primary care visits due to mental health problems and use of psychotropic medication during the COVID-19 pandemic in Finnish adolescents and young adults
Ilari Kuitunen, Mikko Uimonen, Ville Ponkilainen, et al.
Child and Adolescent Psychiatry and Mental Health (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
Bradley Roberts, Zahra Cooper, Stephanie Lu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Waking Up to the Issue! Research Inattention and Sex-Related Differences Warrant More Sleep Studies in Female Athletes
Cody J. Power, Jordan L. Fox, Kirsty J. Elliott‐Sale, et al.
Sports Medicine (2023) Vol. 54, Iss. 3, pp. 565-583
Closed Access | Times Cited: 7
Quality use of publicly subsidised tapentadol in Australia: a population‐based analysis
Ximena Camacho, Andrea L. Schaffer, Jonathan Brett, et al.
Internal Medicine Journal (2024) Vol. 54, Iss. 6, pp. 941-950
Open Access | Times Cited: 2
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis
Ippazio Cosimo Antonazzo, Carla Fornari, Sandy Maumus-Robert, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 2, pp. 178-178
Open Access | Times Cited: 10
Trends in incident diagnoses and drug prescriptions for anxiety and depression during the COVID-19 pandemic: an 18-month follow-up study based on the UK Biobank
Yue Wang, Fenfen Ge, Junren Wang, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Prevalence of antidepressant use in Brazil: a systematic review with meta-analysis
Gustavo Magno Baldin Tiguman, Rogério Hoefler, Marcus Tolentino Silva, et al.
Brazilian Journal of Psychiatry (2023)
Open Access | Times Cited: 4
There’s a Pill for That: Bad Pharmaceutical Scaffolding and Psychiatrization
Zoey Lavallee
Topoi (2024)
Closed Access | Times Cited: 1
Effect of vitamin D supplementation on depression in older Australian adults
Sabbir Tahmidur Rahman, Mary Waterhouse, Briony Duarte Romero, et al.
International Journal of Geriatric Psychiatry (2022) Vol. 38, Iss. 1
Open Access | Times Cited: 6
Prospective Association Between the Dispensing of Antidepressants and of Medications to Treat Osteoporosis in Older Age
Osvaldo P. Almeida, Amy Page, Frank Sanfilippo, et al.
American Journal of Geriatric Psychiatry (2023) Vol. 32, Iss. 3, pp. 349-357
Closed Access | Times Cited: 3
Impact of the COVID-19 pandemic on the consumption patterns of psychotropic drugs and predictors of limited access to medication
Maya Rachidi, Georges Hatem, Melissa Hatem, et al.
The Journal of Medicine Access (2023) Vol. 7, pp. 275508342311637-275508342311637
Open Access | Times Cited: 2
Lessons from the Netherlands for Australia: cross-country comparison of trends in antidepressant dispensing 2013–2021 and contextual factors influencing prescribing
Katharine Wallis, Pieter J. S. Dikken, Piumika Sooriyaarachchi, et al.
Australian Journal of Primary Health (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 2
A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia
Andrea L. Schaffer, Joel Chia, Jonathan Brett, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2022) Vol. 42, Iss. 11, pp. 828-836
Open Access | Times Cited: 4
Multi‐sectoral action to promote psychological wellbeing: Theorising the role of place‐based policy
M. Fisher
Health Promotion Journal of Australia (2023) Vol. 34, Iss. 3, pp. 644-650
Open Access | Times Cited: 2
COVID-19 and the Mental Health of Adolescents in British Columbia
Jane Friesen, Brian Krauth, Brett Wilmer
Canadian Public Policy (2024) Vol. 50, Iss. 2, pp. 256-276
Closed Access
Observational evidence linking psychotropic medicines to the dispensing of opioid agents in later life
Osvaldo P. Almeida, Amy Page, Frank Sanfilippo, et al.
Psychogeriatrics (2024) Vol. 24, Iss. 3, pp. 665-674
Open Access
Co‐design of digital public health substance use resources: A collaboration between young people and experts
Jennifer Debenham, Louise Birrell, Nicola C. Newton, et al.
Health Promotion Journal of Australia (2024)
Open Access
Page 1 - Next Page

Scroll to top